(Press-News.org) Contact information: Joe Dangor
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis
ROCHESTER, Minn. -- Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found. The results were presented today at the 2013 American Society of Hematology Annual Meeting in New Orleans.
"These are early results but they are promising, says the study's lead author, Ayalew Tefferi, M.D. a hematologist at Mayo Clinic. "Some patients in our clinical trial taking imetelstat obtained dramatic responses and there have been some complete responses which is almost unheard of for drug therapy in this disease."
Myelofibrosis is a chronic myeloid cancer in which bone marrow cells that produce blood cells develop and function abnormally. The result is the formation of scar tissue in the bone marrow (fibrosis), severe anemia that often requires transfusion, weakness, fatigue and an enlarged spleen and liver. Patients with myelofibrosis harbor one of several genetic mutations in their blood stem cells, including JAK2, MPL, CALR, ASXL1 and spliceosome pathway mutations.
"Typically, myelofibrosis is characterized by marrow scarring and although patients may derive symptomatic relief from other treatments such as ruxolitinib, they usually do not revert back to normal bone marrow," Dr. Tefferi says. "Some patients in our trial have reverted back to normal bone marrow."
Imetelstat works by inhibiting telomerase activity in tumor cells which leads to cell death.
Researchers studied imetelstat in 33 patients at Mayo Clinic and have now followed the first 22 patients for a minimum of six months. Among the 22, five patients achieved complete or partial remissions, including reversal of bone marrow fibrosis in four of the five patients. Two of the five patients with complete or partial remission have also experienced complete molecular remissions. The overall response rate was 41 percent.
###
MULTIMEDIA ALERT: Video interview is available for journalists on the Mayo Clinic News Network.
Joe Dangor
507-284-5005 (days)
507-284-2511 (evenings)
Email: newsbureau@mayo.edu
Co-authors include Kebede Begna, M.D., Rebecca Laborde, Ph.D., Mrinal Patnaik, M.B.B.S., Curtis Hanson, M.D., Animesh Pardanani, M.B.B.S., Ph.D., Terra Lasho, Darci Zblewski, Christy Finke, Lauren Schimek, and Betsy LaPlant, all of Mayo Clinic and Monic Stuart, M.D., M.P.H. of Geron Corporation.
Financial support for the study was provided by Geron Corporation.
About Mayo Clinic Cancer Center
As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 507-538-7623.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/about and http://www.mayoclinic.org/news.
Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.
Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis
2013-12-06
ELSE PRESS RELEASES FROM THIS DATE:
NASA Goddard planetary instruments score a hat trick
2013-12-06
NASA Goddard planetary instruments score a hat trick
Planetary instruments from NASA's Goddard Space Flight Center in Greenbelt, Md., hit the trifecta on Dec. 4, running three experiments of the same kind at different places in space.
The ...
Study shows how water dissolves stone, molecule by molecule
2013-12-06
Study shows how water dissolves stone, molecule by molecule
International team uses computers, experiments to better predict chemical dissolution
HOUSTON -- (Dec. 5, 2013) -- Scientists from Rice University and the University of Bremen's Center for Marine Environmental Sciences ...
The gene sequencing that everyone can afford in future
2013-12-06
The gene sequencing that everyone can afford in future
DNA sequencing seems to be an eternal theme for human due to the desire of ascertaining the nature of life. Professor QIAN Linmao and his group from Tribology Research Institute, Southwest Jiaotong University were ...
Cigarette smoking after cancer diagnosis increases risk of death
2013-12-06
Cigarette smoking after cancer diagnosis increases risk of death
Study shows it is not too late to stop smoking after cancer diagnosis
PHILADELPHIA — Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with ...
Stomach 'clock' tells us how much to eat
2013-12-05
Stomach 'clock' tells us how much to eat
University of Adelaide researchers have discovered the first evidence that the nerves in the stomach act as a circadian clock, limiting food intake to specific times of the day.
The discovery, published ...
CERN, eat your heart out? U of A research team helps identify an interstellar particle accelerator
2013-12-05
CERN, eat your heart out? U of A research team helps identify an interstellar particle accelerator
Newly released research in Nature Communications from the University of Alberta has identified the existence of a giant cosmic accelerator above the Earth.
By ...
Heads or tails? Random fluctuations in brain cell activity may determine toss-up decisions
2013-12-05
Heads or tails? Random fluctuations in brain cell activity may determine toss-up decisions
Life presents us with choices all the time: salad or pizza for lunch? Tea or coffee afterward? How we make these everyday decisions has been a topic of great ...
An ecosystem-based approach to protect the deep sea from mining
2013-12-05
An ecosystem-based approach to protect the deep sea from mining
Five hundred miles southeast of Hawai'i, in international waters far out of sight of any land, there are vast mineral resources 5,000 meters below the sea.
Manganese nodules, rich in commercially ...
New insights into how human skin attracts mosquitoes could lead to better repellants and traps
2013-12-05
New insights into how human skin attracts mosquitoes could lead to better repellants and traps
Every time a mosquito is lured to the scent of your skin, you're at risk of contracting malaria, dengue fever, West Nile virus, or another deadly disease. A study published by ...
Gut bacteria linked to autism-related behavior in mice
2013-12-05
Gut bacteria linked to autism-related behavior in mice
Mice whose mothers suffered from infection or inflammation during pregnancy are at greater risk for developing behaviors similar to those seen in people with autism spectrum disorders (ASD). Now, researchers reporting in ...